MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...
Grail (GRAL) is jumping for a second straight day, climbing 6% today, after Oracle (ORCL) Chairman Larry Ellison on Tuesday said that blood tests that detect small tumor fragments could be used, in ...
As 2024 was drawing to a close, OpenAI CEO Sam Altman faced two major problems. He wasn’t getting enough server capacity from Microsoft, his company’s biggest backer, to stay ahead of rivals ...
Results that may be inaccessible to you are currently showing.